Cash Equivalents - Vaxart Inc (NASDAQ:VXRT) - Alpha Spread

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.8344 USD -7.91% Market Closed
Market Cap: 189.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vaxart Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Cash Equivalents
$38m
CAGR 3-Years
-21%
CAGR 5-Years
18%
CAGR 10-Years
-7%
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is Vaxart Inc's Cash Equivalents?
Cash Equivalents
38m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Cash Equivalents amounts to 38m USD.

What is Vaxart Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-7%

Over the last year, the Cash Equivalents growth was 0%. The average annual Cash Equivalents growth rates for Vaxart Inc have been -21% over the past three years , 18% over the past five years , and -7% over the past ten years .

Back to Top